Physicians' Academy for Cardiovascular Education

A new dawn for heart failure treatment?

Transatlantic Dialogues on Controversies in Contemporary Cardiology 2016, Rome

Co-morbities and humility

Lecture - Aug. 28, 2016 - Rome, Italy - Marc A Pfeffer, MD - Boston, MA, USA

Dr. Marc Pfeffer (Boston, MA, USA) discusses how insights on the effect of antidiabetic drugs on CV outcomes has evolved over time, culminating in the benefit seen with empagliflozin on mortality and on heart failure. The latter benefit deserves more attention.

Educational information

Brigham and Women’s Transatlantic Dialogues on Controversies in Contemporary Cardiology

This lecture is part of a special educational symposium exploring controversies in cardiovascular risk management and compared and contrasted best common practices and guidelines on both sides of the Atlantic. American and European experts discussed novel insights from basic and translational cardiovascular science in the context of ongoing and future clinical studies

The program is an initiative of research leaders from the Brigham and Women’s Hospital, Boston, USA in collaboration with the PACE foundation.


Marc A Pfeffer, MD - Victor J. Dzau Professor of Medicine Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Faculty did not receive an honorarium for their lectures

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: